computational-fluid-dynamics-for-mixing-studies
Mixing in biomanufacturing holds surprising process risk, leading to inconsistent product quality and batch failures. Traditional scale-up studies are slow and expensive, leaving too many unknowns. Discover how computational fluid dynamics for mixing studies offers a modern solution to de-risk your process.
Menu
De-Risking Scale-Up: A Practical Look at Computational Fluid Dynamics for Mixing
Frequently Asked Questions (FAQ)
The Push for Better Process Understanding
Common Headaches in Mixing and a Modern Solution
How Leukocare Can Support These Challenges
The Value of a Predictive, Data-Driven Approach
De-Risking Scale-Up: A Practical Look at Computational Fluid Dynamics for Mixing
Mixing is one of those steps in biomanufacturing that seems simple on the surface but holds a surprising amount of process risk. [1] It happens at nearly every stage, from upstream cell culture to downstream purification and final formulation. [2, 3] When mixing goes wrong, the consequences are serious: inconsistent product quality, aggregation, and even batch failure. [4] For years, the industry has relied on physical studies: building scale-down models and running countless experiments. This approach is slow, expensive, and doesn’t always predict what will happen in a full-scale production vessel.
The Push for Better Process Understanding
The biopharma industry is moving toward more complex molecules and processes. These trends demand a deeper, more fundamental understanding of our manufacturing processes. [5, 6] Regulatory bodies like the FDA are also encouraging this shift through initiatives like Quality by Design (QbD), which emphasizes building quality into a product from the start based on solid science and risk management. The old "try-it-and-see" way of developing processes just doesn't work anymore. [7, 8, 9] It’s too slow and leaves too many unknowns.
Common Headaches in Mixing and a Modern Solution
If you're in CMC or Drug Product development, you've probably run into some familiar mixing problems.
The anxiety of scale-up: What works perfectly in a 5-liter lab vessel can behave unexpectedly in a 2,000-liter single-use bag. Scaling rules like tip speed and power per volume are useful guides, but they don’t capture the full complexity of fluid dynamics. [10]
Burning through time and material: Physical mixing studies are a major drain on resources. They consume expensive, often limited, drug substance and can add months to a development timeline. [11]
Handling sensitive new molecules: Many new modalities (like viral vectors, ADCs, or mRNA-LNPs) are highly sensitive to physical stress. High shear zones in a mixing tank can damage or aggregate these complex molecules, compromising the final product. [12]
A lack of visibility: It’s impossible to see what is happening inside a stainless-steel reactor or opaque single-use system. Are there dead zones where mixing is poor? [14] Are shear forces dangerously high near the impeller?
This is where Computational Fluid Dynamics (CFD) comes in. CFD is a simulation tool that creates a "digital twin" of your mixing vessel. By solving fundamental fluid flow equations, it allows you to visualize flow patterns, map shear stress, predict mixing times, and identify potential problem areas. The result is a clear picture of your process, all without running a single physical experiment. [16] It helps turn process development from a guessing game into a predictive science. [17]
How Leukocare Can Support These Challenges
At Leukocare, we see CFD not as a standalone service, but as an integrated part of a data-driven formulation and drug product development strategy. It is one of the tools in our Smart Formulation Platform, allowing us to build a robust, science-based process that protects your molecule from the start.
We use modeling to provide practical answers that move your project forward.
For a fast-track virtual biotech, CFD helps de-risk technology transfer and scale-up. By simulating the process in the target manufacturing equipment early on, we can identify and solve potential issues, helping you build a stronger CMC package and achieve a cleaner, faster path to BLA.
For a mid-sized biotech facing a novel challenge—perhaps a high-viscosity formulation or a new single-use mixer—we can conduct a focused CFD study. This gives you the info to make smart decisions, all while helping your internal team without cutting out trusted partners or causing problems.
For a large pharma company tackling a new modality, we combine our formulation knowledge with CFD to mitigate specific risks. For instance, we can model the shear forces a viral vector will experience during mixing and adjust process parameters to ensure the product remains stable and effective.
The Value of a Predictive, Data-Driven Approach
Adding CFD to drug product development brings clear and real benefits. It's about working smarter, not just harder.
Reduced Risk: By predicting and addressing mixing problems before they happen, you can avoid the immense cost and delays of a failed manufacturing batch.
Faster Timelines: Simulation reduces the need for extensive physical experiments, shortening process characterization and validation timelines. This helps get your product to the clinic, and to patients, sooner. [11]
Material Savings: Running simulations instead of physical tests saves a significant amount of valuable drug substance, which is especially important in early development when material is scarce.
Deep Process Insight: CFD gives you a level of process insight that's hard to get with just physical tests. [18] This knowledge is really important for regulatory paperwork, fixing problems, and always getting better. [19]
Using tools like CFD is about more than just generating data. It’s about building a strong process by truly understanding the physics involved. [20] It's about having a partner who can make sense of that data for your molecule, your goals, and your timeline. It’s how we deliver on our promise: a formulation and process designed by science, guided by data, and built for regulatory success.
Frequently Asked Questions (FAQ)
1. How accurate are CFD simulations compared to real-world experiments?
When set up and checked properly, CFD models can be very accurate, often predicting key things like torque and mass transfer within about 20% of what you'd see in experiments. The idea isn't to ditch physical experiments entirely, but to make them smarter. [21] We use targeted lab experiments to validate the model, then use the simulation to explore a wide range of conditions quickly and efficiently.
2. Is CFD only useful for late-stage development and scale-up?
Not at all. CFD is useful right from the start of development. It can help pick the right equipment (like impeller type, vessel shape) and set initial process details even before you have a lot of material. This builds a strong foundation for your process and helps you steer clear of problems later. [16]
3. What information do you need from us to build a CFD model?
To build an accurate model, we usually need the precise shape of the mixing vessel and its parts (like impellers and baffles), the liquid's physical traits (viscosity, density), and the process settings you plan to use (like impeller speed, flow rates). We work collaboratively with your team and equipment vendors to gather this information.
4. We already have an established relationship with a CDMO. How would this work?
We act as a specialized partner, focused on formulation and drug product development. We can work directly with your team to solve specific mixing or processing challenges, sharing our findings with you and your CDMO. This helps their services without getting in the way, making sure your process is as strong as it can be. We act as a quiet, smooth, science-backed extension of your team.
